Organization
Cerner LifeSciences
1 abstract
Abstract
A FINANCIAL IMPACT ASSESSMENT OF INTRODUCING LUMIRACOXIB ONTO THE FORMULARY OF THE UK NATIONAL HEALTH SERVICE FOR THE MANAGEMENT OF PATIENTS WITH OSTEOARTHRITISOrg: Health Economics and Health Services Research, Cerner LifeSciences, Beverly Hills Cancer Care, Novartis Pharmaceuticals Corporation, East Hanover, NJ,